You are here

Novo Nordisk

Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies

Yahoo/Benzinga

Wed, 06/11/25 - 11:29 am

Deep Apple Therapeutics

Nvidia announces massive new initiatives in pharma and clinical research

Forbes

Wed, 06/11/25 - 10:52 am

artificial intelligence

Novo Nordisk starts new CagriSema weightloss drug trial

Investing.com

Tue, 06/10/25 - 11:50 am

clinical trials

The biggest obesity deals of 2025 so far

Pharma Voice

Mon, 06/9/25 - 10:58 am

Carmot Therapeutics

United Laboratories International

Medicare negotiations underway to lower prices for next batch of drugs

NPR

Wed, 06/4/25 - 10:42 pm

Inflation Reduction Act

Wegovy use up 50% among US teens

Yahoo/Reuters

Tue, 06/3/25 - 11:12 am

Regeneron's weight-loss drug combo helps preserve muscle in study

MSN/Reuters

Tue, 06/3/25 - 10:43 am

clinical trials

Muscle-sparing obesity drug safe for Phase 3 trial, Veru says

BioPharma Dive

Wed, 05/28/25 - 10:58 pm

clinical trials

GLP-1 prescriptions for weight loss soar, despite obstacles

BioPharma Dive

Wed, 05/28/25 - 10:58 am

Turning the page: Novo’s CEO transition reflects Big Pharma’s era of change

Pharma Voice

Tue, 05/27/25 - 11:10 am

pharma industry

Did Eli Lilly Just Say Checkmate to Novo Nordisk?

Motley Fool

Thu, 05/22/25 - 11:40 am

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs

CNBC

Thu, 05/22/25 - 10:50 am

As Eli Lilly outperforms Novo in market, it also replaces its rival in annual IDEA Innovation rankings

Fierce Pharma

Wed, 05/21/25 - 11:53 am

Noom is offering smaller doses of compounded Wegovy for weight loss

Quartz

Wed, 05/21/25 - 11:11 am

Novo CEO to depart as obesity drugmaker’s challenges rise

BioPharma Dive

Fri, 05/16/25 - 11:47 am

Lars Jørgensen

Pathos AI secures $365M series D to fund trial of Novo Nordisk solid tumor drug

Fierce Biotech

Thu, 05/15/25 - 10:57 am

Prelude Therapeutics

Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs

Fierce Biotech

Wed, 05/14/25 - 10:56 am

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial

Investing.com

Sun, 05/11/25 - 10:06 pm

clinical trials

Novo's Wegovy takes a hit from compounders, but company expects faster second-half growth

Fierce Pharma

Wed, 05/7/25 - 11:46 am

Are pharma’s DTC platforms actually creating engagement with patients?

Medical Marketing and Media

Tue, 05/6/25 - 10:27 am

patient engagement

Pages